Open AccessS127: QUIZARTINIB WITH DECITABINE AND VENETOCLAX (TRIPLET) IS ACTIVE IN PATIENTS WITH FLT3‐ITD MUTATED ACUTE MYELOID LEUKEMIA ‐ A PHASE I/II STUDY
Author(s) -
Yilmaz M.,
Muftuoglu M.,
Kantarjian H.,
DiNardo C.,
Kadia T.,
Borthakur G.,
Pemmaraju N.,
Short N.,
Alvarado Y.,
Maiti A.,
Masarova L.,
Montalban Bravo G.,
Loghavi S.,
Patel K.,
Kornblau S.,
Jabbour E.,
GarciaManero G.,
Andreeff M.,
Daver N.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843400.36721.1d
Subject(s) - decitabine , medicine , ven , venetoclax , azacitidine , bone marrow , gastroenterology , oncology , surgery , nuclear medicine , leukemia , chronic lymphocytic leukemia , computer science , gene expression , dna methylation , gene , biochemistry , chemistry , computer security